Tresiba 100 U/mL

Tresiba 100 U/mL is a long-acting insulin injection used for managing blood sugar levels in diabetes. This solution is designed for subcutaneous use and is manufactured by Novo Nordisk in the USA.

Tresiba 100 U/mL is primarily used for the management of diabetes. It helps control blood sugar levels over an extended period, making it suitable for daily use. This insulin injection is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise. Tresiba 100 U/mL is designed to provide a steady release of insulin, helping to maintain stable blood sugar levels throughout the day.

Tresiba 100 U/mL works by mimicking the action of natural insulin in the body. It helps cells absorb glucose from the bloodstream, which can lead to lower blood sugar levels. Some users may experience common effects such as injection site reactions, weight gain, or hypoglycemia if the dosage is not carefully managed. It is important to monitor blood sugar levels regularly while using this medication.

Tresiba 100 U/mL should be stored properly to maintain its effectiveness. It is important to keep the vial refrigerated and protect it from light and heat. Always check the label for specific storage instructions. This insulin injection should be used as directed by a healthcare provider. Do not share needles or syringes with others to prevent the spread of infections.

Tresiba 100 U/mL may interact with other medications, including oral hypoglycemic agents, corticosteroids, and certain antidepressants. Alcohol consumption can also affect blood sugar levels and should be monitored carefully. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions. It is important to follow the advice of a healthcare professional when using Tresiba 100 U/mL.